Drug Shortage Report for FAMPYRA

Last updated on 2022-11-18 History
Report ID 173164
Drug Identification Number 02379910
Brand name FAMPYRA
Common or Proper name fampridine
Company Name BIOGEN CANADA INC
Market Status MARKETED
Active Ingredient(s) FAMPRIDINE
Strength(s) 10MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 14 tablets per bottle (x4 Bottles)
ATC code N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-11-07
Actual start date
Estimated end date 2022-11-17
Actual end date 2022-11-17
Shortage status Resolved
Updated date 2022-11-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3300 BLOOR STREET WEST, WEST TOWER, SUITE 1200
TORONTO, ONTARIO
CANADA M8X 2X2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-11-18 English Compare
v8 2022-11-17 French Compare
v7 2022-11-17 English Compare
v6 2022-11-17 English Compare
v5 2022-11-11 French Compare
v4 2022-11-11 English Compare
v3 2022-11-08 English Compare
v2 2022-10-31 French Compare
v1 2022-10-31 English Compare

Showing 1 to 9 of 9